Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
Blood|July 20, 2002
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)Jeanette Lundin, Eva Kimby, Magnus Björkholm, et al.Plos One|November 26, 2009
Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic targetSylvaine You, Lynn Poulton, Steve Cobbold, et al.Blood|July 19, 2003
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantationSuparno Chakrabarti, Donald W Milligan, Deenan Pillay, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|June 16, 2004
Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitisConor C Murphy, Kathrin Greiner, Jarka Plskova, et al.Frontiers in Immunology|June 6, 2018
Non-Invasive Multiphoton Imaging of Islets Transplanted Into the Pinna of the NOD Mouse Ear Reveals the Immediate Effect of Anti-CD3 Treatment in Autoimmune DiabetesRobert A Benson, Fabien Garcon, Asha Recino, et al.The Journal of Clinical Investigation|February 25, 2010
Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in miceMichio Tomura, Tetsuya Honda, Hideaki Tanizaki, et al.Molecular Genetics and Metabolism Reports|November 30, 2016
Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe diseaseBaodong Sun, Suhrad G Banugaria, Sean N Prater, et al.Journal of Neurology|July 27, 2005
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapyAlasdair J Coles, Amanda Cox, Emmanuelle Le Page, et al.Journal of Clinical Pharmacology|February 12, 2010
Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetesGeoff Hale, Peppy Rebello, Ibrahim Al Bakir, et al.European Journal of Immunology|January 18, 2014
Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challengeNatasha Whibley, Donna M Maccallum, Mark A Vickers, et al.Pageof 15